Ashley Schnakenberg Martin, PhD
Assistant Professor
Research & Publications
Biography
News
Coauthors
Selected Publications
- A Guide for the Implementation of Group-Based Metacognitive Reflection and Insight Therapy (MERITg)Martin A, Bullock J, Fiszdon J, Stacy M, Martino S, James A, Lysaker P. A Guide for the Implementation of Group-Based Metacognitive Reflection and Insight Therapy (MERITg). Journal Of Contemporary Psychotherapy 2022, 53: 91-98. DOI: 10.1007/s10879-022-09560-9.
- Translating an Integrative Metacognitive Model of Psychotherapy for Serious Mental Illness Into a Group Format: A Pilot Investigation on FeasibilityMartin A, Bullock J, Fiszdon J, Stacy M, Martino S, James AV, Wiesepape C, Lysaker PH. Translating an Integrative Metacognitive Model of Psychotherapy for Serious Mental Illness Into a Group Format: A Pilot Investigation on Feasibility. Psychological Services 2024, 21: 130-138. PMID: 36066852, PMCID: PMC10484016, DOI: 10.1037/ser0000706.
- Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorderSchnakenberg Martin AM, Bartolomeo L, Howell J, Hetrick WP, Bolbecker AR, Breier A, Kidd G, O’Donnell B. Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder. European Archives Of Psychiatry And Clinical Neuroscience 2017, 268: 653-661. PMID: 28936548, PMCID: PMC7126185, DOI: 10.1007/s00406-017-0839-1.
- Differential Cognitive Performance in Females and Males with Regular Cannabis UseMartin A, D’Souza D, Newman SD, Hetrick WP, O’Donnell B. Differential Cognitive Performance in Females and Males with Regular Cannabis Use. Journal Of The International Neuropsychological Society 2021, 27: 570-580. PMID: 34261548, PMCID: PMC8830784, DOI: 10.1017/s1355617721000606.
- Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosisMartin A, Bonfils KA, Davis BJ, Smith EA, Schuder K, Lysaker PH. Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis. Schizophrenia Research Cognition 2016, 6: 15-21. PMID: 28740820, PMCID: PMC5514308, DOI: 10.1016/j.scog.2016.09.001.
- Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responsesSchnakenberg Martin A, Flynn L, Sefik E, Luddy C, Cortes-Briones J, Skosnik P, Pittman B, Ranganathan M, D’Souza D. Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses. Psychopharmacology 2023, 240: 1235-1246. PMID: 37045988, DOI: 10.1007/s00213-023-06356-0.
- The Relationship Between Cannabinoids and Neural Oscillations: How Cannabis Disrupts Sensation, Perception, and CognitionSyed S, Martin A, Cortes-Briones J, Skosnik P. The Relationship Between Cannabinoids and Neural Oscillations: How Cannabis Disrupts Sensation, Perception, and Cognition. Clinical EEG And Neuroscience 2022, 54: 359-369. PMID: 36426543, DOI: 10.1177/15500594221138280.
- The relationship between cannabis use and taurine: A MRS and metabolomics studyNewman S, Martin A, Raymond D, Cheng H, Wilson L, Barnes S, O’Donnell B. The relationship between cannabis use and taurine: A MRS and metabolomics study. PLOS ONE 2022, 17: e0269280. PMID: 35653401, PMCID: PMC9162360, DOI: 10.1371/journal.pone.0269280.
- Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and BehaviorGanesh S, Cortes-Briones J, Martin A, Skosnik PD, D'Souza DC, Ranganathan M. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior. Cannabis And Cannabinoid Research 2022, 8: 846-856. PMID: 35319274, PMCID: PMC10589482, DOI: 10.1089/can.2021.0166.
- Metacognition, Adaptation, and Mental HealthSchnakenberg Martin A, Lysaker P. Metacognition, Adaptation, and Mental Health. Biological Psychiatry 2021, 91: e31-e32. PMID: 34961623, DOI: 10.1016/j.biopsych.2021.09.028.
- Treatment outcomes in individuals diagnosed with comorbid opioid use disorder and Posttraumatic stress disorder: A reviewMeshberg-Cohen S, MacLean R, Martin A, Sofuoglu M, Petrakis IL. Treatment outcomes in individuals diagnosed with comorbid opioid use disorder and Posttraumatic stress disorder: A review. Addictive Behaviors 2021, 122: 107026. PMID: 34182307, DOI: 10.1016/j.addbeh.2021.107026.
- Altered cerebellar-cortical resting-state functional connectivity in cannabis usersMartin A, Kim DJ, Newman SD, Cheng H, Hetrick WP, Mackie K, O’Donnell B. Altered cerebellar-cortical resting-state functional connectivity in cannabis users. Journal Of Psychopharmacology 2021, 35: 823-832. PMID: 34034553, PMCID: PMC8813046, DOI: 10.1177/02698811211019291.
- Meaning, integration, and the self in serious mental illness: Implications of research in metacognition for psychiatric rehabilitation.Lysaker PH, Kukla M, Leonhardt BL, Hamm JA, Schnakenberg Martin A, Zalzala AB, Gagen EC, Hasson-Ohayon I. Meaning, integration, and the self in serious mental illness: Implications of research in metacognition for psychiatric rehabilitation. Psychiatric Rehabilitation Journal 2020, 43: 275-283. PMID: 32790437, DOI: 10.1037/prj0000436.
- In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteersSchindler EAD, Schnakenberg Martin AM, Sewell RA, Ranganathan M, DeForest A, Pittman BP, Perrino A, D’Souza D. In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers. Psychopharmacology 2020, 237: 3097-3107. PMID: 32632491, DOI: 10.1007/s00213-020-05595-9.
- An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis usersNewman SD, Cheng H, Kim DJ, Schnakenberg-Martin A, Dydak U, Dharmadhikari S, Hetrick W, O’Donnell B. An investigation of the relationship between glutamate and resting state connectivity in chronic cannabis users. Brain Imaging And Behavior 2019, 14: 2062-2071. PMID: 31302844, PMCID: PMC6955389, DOI: 10.1007/s11682-019-00165-w.
- Individuals with psychosis and a lifetime history of cannabis use show greater deficits in emotional experience compared to non-using peersMartin A, Lysaker PH. Individuals with psychosis and a lifetime history of cannabis use show greater deficits in emotional experience compared to non-using peers. Journal Of Mental Health 2019, 29: 77-83. PMID: 30822177, DOI: 10.1080/09638237.2018.1487540.
- An Investigation of Neurochemical Changes in Chronic Cannabis Users.Newman SD, Cheng H, Schnakenberg Martin A, Dydak U, Dharmadhikari S, Hetrick W, O'Donnell B. An Investigation of Neurochemical Changes in Chronic Cannabis Users. Frontiers In Human Neuroscience 2019, 13: 318. PMID: 31607877, PMCID: PMC6761299, DOI: 10.3389/fnhum.2019.00318.
- Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapyLysaker P, Kukla M, Vohs J, Martin A, Buck K, Ohayon I. Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapy. Journal Of Experimental Psychopathology 2019, 10: 2043808718814992. DOI: 10.1177/2043808718814992.
- Aberrant structural–functional coupling in adult cannabis usersKim D, Martin A, Shin Y, Jo HJ, Cheng H, Newman SD, Sporns O, Hetrick WP, Calkins E, O'Donnell BF. Aberrant structural–functional coupling in adult cannabis users. Human Brain Mapping 2018, 40: 252-261. PMID: 30203892, PMCID: PMC6289814, DOI: 10.1002/hbm.24369.
- Disturbances of postural sway components in cannabis users.Bolbecker AR, Apthorp D, Martin AS, Tahayori B, Moravec L, Gomez KL, O'Donnell BF, Newman SD, Hetrick WP. Disturbances of postural sway components in cannabis users. Drug And Alcohol Dependence 2018, 190: 54-61. PMID: 29983392, PMCID: PMC7185833, DOI: 10.1016/j.drugalcdep.2018.05.012.
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trialBoggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, Schnakenberg Martin AM, Thurnauer H, Davies A, D’Souza D, Ranganathan M. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology 2018, 235: 1923-1932. PMID: 29619533, DOI: 10.1007/s00213-018-4885-9.
- Acute Phencyclidine Alters Neural Oscillations Evoked by Tones in the Auditory Cortex of RatsMartin A, OʼDonnell BF, Millward JB, Vohs JL, Leishman E, Bolbecker AR, Rass O, Morzorati SL. Acute Phencyclidine Alters Neural Oscillations Evoked by Tones in the Auditory Cortex of Rats. Neuropsychobiology 2017, 75: 53-62. PMID: 29065422, PMCID: PMC5752597, DOI: 10.1159/000480511.
- Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal informationRanganathan M, Radhakrishnan R, Addy PH, Schnakenberg-Martin AM, Williams AH, Carbuto M, Elander J, Pittman B, Sewell R, Skosnik PD, D'Souza DC. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2017, 79: 176-183. PMID: 28642081, DOI: 10.1016/j.pnpbp.2017.06.019.
- The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognitionHelle S, Løberg EM, Gjestad R, Martin A, Lysaker PH. The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition. Psychiatry Research 2017, 250: 92-98. PMID: 28152399, DOI: 10.1016/j.psychres.2017.01.047.
- Emerging behavioral and psychotherapeutic interventions for schizophreniaO’Donnell B, Schnakenberg Martin A. Emerging behavioral and psychotherapeutic interventions for schizophrenia. Dusunen Adam The Journal Of Psychiatry And Neurological Sciences 2016, 189-201. DOI: 10.5350/dajpn20162903001.
- GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THCRadhakrishnan R, Skosnik PD, Cortes-Briones J, Sewell RA, Carbuto M, Schnakenberg A, Cahill J, Bois F, Gunduz-Bruce H, Pittman B, Ranganathan M, D'Souza DC. GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC. Neuropsychopharmacology 2015, 40: 2047-2056. PMID: 25728472, PMCID: PMC4839528, DOI: 10.1038/npp.2015.58.
- Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholismRanganathan M, Sewell RA, Carbuto M, Elander J, Schnakenberg A, Radhakrishnan R, Pittman B, D’Souza D. Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism. Psychopharmacology 2014, 231: 2385-2393. PMID: 24424782, DOI: 10.1007/s00213-013-3402-4.
- Acute effects of THC on time perception in frequent and infrequent cannabis usersSewell RA, Schnakenberg A, Elander J, Radhakrishnan R, Williams A, Skosnik PD, Pittman B, Ranganathan M, D’Souza D. Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology 2012, 226: 401-413. PMID: 23179965, PMCID: PMC3581701, DOI: 10.1007/s00213-012-2915-6.
- Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in HumansRanganathan M, Schnakenberg A, Skosnik PD, Cohen BM, Pittman B, Sewell RA, D'Souza DC. Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans. Biological Psychiatry 2012, 72: 871-879. PMID: 22817868, PMCID: PMC3638802, DOI: 10.1016/j.biopsych.2012.06.012.
- Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in HumansD'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, Carbuto M, Elander J, Schnakenberg A, Pittman B, Sewell RA, Ranganathan M, Mathalon D. Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans. Neuropsychopharmacology 2012, 37: 1632-1646. PMID: 22334121, PMCID: PMC3358754, DOI: 10.1038/npp.2012.8.
- The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case historiesCarbuto M, Sewell RA, Williams A, Forselius-Bielen K, Braley G, Elander J, Pittman B, Schnakenberg A, Bhakta S, Perry E, Ranganathan M, D’Souza D, The Yale THC Study Group. The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories. Psychopharmacology 2011, 219: 885-896. PMID: 21845389, DOI: 10.1007/s00213-011-2417-y.